<SEC-DOCUMENT>0001610717-24-000400.txt : 20240717
<SEC-HEADER>0001610717-24-000400.hdr.sgml : 20240717
<ACCEPTANCE-DATETIME>20240717203650
ACCESSION NUMBER:		0001610717-24-000400
CONFORMED SUBMISSION TYPE:	144
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20240717
DATE AS OF CHANGE:		20240717

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			PUMA BIOTECHNOLOGY, INC.
		CENTRAL INDEX KEY:			0001401667
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				770683487
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		144
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	001-35703
		FILM NUMBER:		241123514

	BUSINESS ADDRESS:	
		STREET 1:		10880 WILSHIRE BLVD.
		STREET 2:		SUITE 2150
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024
		BUSINESS PHONE:		(424) 248-6500

	MAIL ADDRESS:	
		STREET 1:		10880 WILSHIRE BLVD.
		STREET 2:		SUITE 2150
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	INNOVATIVE ACQUISITIONS CORP
		DATE OF NAME CHANGE:	20070601

REPORTING-OWNER:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUNT DOUGLAS M
		CENTRAL INDEX KEY:			0001727172
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		144

	MAIL ADDRESS:	
		STREET 1:		C/O PUMA BIOTECHNOLOGY,INC.
		STREET 2:		10880 WILSHIRE BOULEVARD, SUITE 2150
		CITY:			LOS ANGELES
		STATE:			CA
		ZIP:			90024
</SEC-HEADER>
<DOCUMENT>
<TYPE>144
<SEQUENCE>1
<FILENAME>primary_doc.xml
<TEXT>
<XML>
<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001727172</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001401667</issuerCik>
      <issuerName>PUMA BIOTECHNOLOGY, INC.</issuerName>
      <secFileNumber>001-35703</secFileNumber>
      <issuerAddress>
        <com:street1>10880 WILSHIRE BLVD.</com:street1>
        <com:street2>SUITE 2150</com:street2>
        <com:city>LOS ANGELES</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>90024</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>(424) 248-6500</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>HUNT DOUGLAS M</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>Muriel Siebert &amp; Co., Inc.</name>
        <address>
          <com:street1>4141 NE 2nd Avenue, Suite 201</com:street1>
          <com:city>Miami</com:city>
          <com:stateOrCountry>FL</com:stateOrCountry>
          <com:zipCode>33137</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>3637</noOfUnitsSold>
      <aggregateMarketValue>14366.15</aggregateMarketValue>
      <noOfUnitsOutstanding>48238850</noOfUnitsOutstanding>
      <approxSaleDate>07/17/2024</approxSaleDate>
      <securitiesExchangeName>NASDAQGS</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <acquiredDate>02/12/2024</acquiredDate>
      <natureOfAcquisitionTransaction>Restricted Stock Unit Grant</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>PUMA BIOTECHNOLOGY, INC</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>37894</amountOfSecuritiesAcquired>
      <paymentDate>02/12/2024</paymentDate>
      <natureOfPayment>Compensation for Services Rendered</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>Douglas M. Hunt</name>
        <address>
          <com:street1>c/o Puma Biotechnology, Inc.</com:street1>
          <com:street2>10880 Wilshire Boulevard, Suite 2150</com:street2>
          <com:city>Los Angeles</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>90024</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>Common Stock</securitiesClassTitle>
      <saleDate>07/02/2024</saleDate>
      <amountOfSecuritiesSold>4349</amountOfSecuritiesSold>
      <grossProceeds>14214.71</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>07/17/2024</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>12/14/2020</planAdoptionDate>
      </planAdoptionDates>
      <signature>/s/ Gordon Esplin, Attorney-in-Fact for Douglas M. Hunt</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
